Why Bristol Myers (BMY) is Poised to Beat Earnings Estimates AgainZacks Investment Research • 01/06/26
Bristol Myers Squibb to Present at J.P. Morgan's 44th Annual Healthcare ConferenceBusiness Wire • 01/02/26
Chevron, Kimberly-Clark Among 16 Companies To Kick Off 2026 With Annual Dividend Increases In JanuarySeeking Alpha • 12/27/25
Bristol-Myers Squibb: Contrarian Buy For Dividend Hunters, Despite Mounting Growth HeadwindsSeeking Alpha • 12/24/25
Will the Recent Pricing Deal With the Government Impact BMY's Sales?Zacks Investment Research • 12/23/25
Bristol-Myers Squibb: Pharma Giant Still Undervalued And Printing Cash Despite Patent CliffSeeking Alpha • 12/23/25
Nine pharmaceutical companies including Bristol-Myers Squibb, GSK and Merck agreed to lower the prices that certain federal government programs and patients payWSJ • 12/19/25
Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for AmericansBusiness Wire • 12/19/25
Bristol Myers Squibb to Report Results for Fourth Quarter 2025 on February 5, 2026Business Wire • 12/18/25